High levels of unconjugated bilirubin (UCB) in newborn children is associated with a reduction in hepatic UDP glucuronosyltransferase (UGT) 1A1 activity that can lead to CNS toxicity, brain damage, and even death. Little is known regarding those events that lead to UCB accumulation in brain tissue, and therefore, we sought to duplicate this condition in mice. The human
UGT1
locus, encoding all 9-
UGT1A
genes including
UGT1A1
, was expressed in
Ugt1
−/−
mice. Because the most common clinical condition associated with jaundice in adults is Gilbert’s syndrome, which is characterized by an allelic polymorphism in the
UGT1A1
promoter, hyperbilirubinemia was monitored in humanized
UGT1
mice that expressed either the Gilbert’s
UGT1A1*28
allele [
Tg(UGT1
A1*28
)Ugt1
−/−
mice] or the normal
UGT1A1*1
allele [
Tg(UGT1
A1*1
)Ugt1
−/−
mice]. Adult
Tg(UGT1
A1*28
)Ugt1
−/−
mice expressed elevated levels of total bilirubin (TB) compared with
Tg(UGT1
A1*1
)Ugt1
−/−
mice, confirming that the promoter polymorphism associated with the
UGT1A1*28
allele contributes to hyperbilirubinemia in mice. However, TB accumulated to near toxic levels during neonatal development, a finding that is independent of the Gilbert’s
UGT1A1*28
promoter polymorphism. Whereas serum TB levels eventually returned to adult levels, TB clearance in neonatal mice was not associated with hepatic UGT1A1 expression. In ∼10% of the humanized
UGT1
mice, peak TB levels culminated in seizures followed by death. UCB deposition in brain tissue and the ensuing seizures were associated with developmental milestones and can be prevented by enhancing regulation of the
UGT1A1
gene in neonatal mice.